Skip to main content
OpenTrials
Completed

NCT Number: NCT03981770

Characterisation of Gut Microbiota, Bispectral Index Data and Plasma Kynurenine in Patients Undergoing Thyroid Surgery

The study is a case-controlled observational trial. Forty patients will be divided into 2 groups (good or poor sleepers) depending on their first postoperative night Bispectral index data. Firstly, this study aims to characterise the lung microbiota in patients treated with thyroid surgery. Secondly, it aims to evaluate microbiota and its influence on plasma kynurenine.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sleep Deprivation Dyssomnias Mental Disorders Nervous System Diseases Neurologic Manifestations Pathological Conditions, Signs and Symptoms Signs and Symptoms Sleep Wake Disorders

Age range

18 year–65 year

Sex eligibility

Male

Study type

Observational

Primary location

the First Hospital of China Medical University

Shenyang, Liaoning, 110001, China

About this study

The study is a case-controlled observational trial. Forty patients will be divided into 2 groups (good or poor sleepers) depending on their first postoperative night Bispectral index data. Firstly, this study aims to characterise the lung microbiota in patients treated with thyroid surgery. Secondly, it aims to evaluate microbiota and its influence on plasma kynurenine.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ethnic Chinese;
  • age, 18 to 65 years old;
  • American Society of Anaesthesiologists (ASA) physical status I or II

Exclusion criteria

  • Cognitive difficulties
  • Affiliated with the Social Security System
  • Partial or complete gastrectomy
  • Previous esophageal surgery
  • Inability to conform to the study's requirements
  • Deprivation of a right to decide by an administrative or juridical entity
  • Ongoing participation or participation in another study <1 month ago

Treatment and study plan

General anesthesia

Drug

For maintenance of propofol anesthesia, total intravenous anesthesia was administered by using propofol (Fresenius Kabi, Austria GmbH) at a plasma target concentration (Marsh pharmacokinetic model software) of 2.5-4 μg/ml. Remifentanil (0.2-0.5 μg/kg/min) was given to all patients during the operation.

Primary outcomes

  1. gut microbiota

    Time frame: the first postoperative night

    this study will characterise the gut microbiota in 2 groups of 30 patients.

Secondary outcomes

  1. Bispectral index data

    Time frame: the first postoperative night

    this study will characterise the Bispectral index data in 2 groups of 30 patients

  2. plasma kynurenine concentrations

    Time frame: baseline and the first postoperative night

    this study will characterise the plasma kynurenine concentrations in 2 groups of 30 patients

Sponsors and collaborators

Lead sponsor

China Medical University, China

Other

Registry information

Important dates

Study start
2019
Primary completion
2019
Study completion
2020
First posted
Jun 11, 2019
Registry last updated
Jan 28, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.